finanzen.net
09.11.2019 02:39
Bewerten
(0)

PharmaCielo Announces RSU Grant

TORONTO, Nov. 8, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO, OTC:PHCEF) today announced that on November 5, 2019 (the "Grant Date") the board of directors approved and granted 25,000 restricted share units ("RSUs") to Carlos Manuel Uribe, a director of the Company, which all vest on the Grant Date. Each RSU entitles the holder to receive one common share in the capital of the Company (each a "Common Share") upon vesting.

PharmaCielo Ltd. (CNW Group/PharmaCielo Ltd.)

The RSUs are governed by the RSU plan approved by the shareholders of the Company on May 23, 2019 (the "RSU Plan"). The number of Common Shares that may be reserved for issuance pursuant to the awards granted under the RSU Plan is 3,531,125. After this issuance of RSUs to Mr. Uribe, there are 1,158,000 RSUs issued and outstanding.

About PharmaCielo
PharmaCielo Ltd. (TSXV:PCLO, OTC:PHCEF) is a global company, headquartered in Canada, with a focus on ethically and sustainably processing and supplying all natural, medicinal-grade cannabis oil extracts and related products to large channel distributors. PharmaCielo's principal (and wholly owned) subsidiary is PharmaCielo Colombia Holdings S.A.S., headquartered at its nursery and propagation centre located in Rionegro, Colombia.

The boards of directors and executive teams of both PharmaCielo and PharmaCielo Colombia Holdings are comprised of a diversely talented group of international business executives and specialists with relevant and varied expertise. PharmaCielo recognized the significant role that Colombia's ideal location will play in building a sustainable business in the medical cannabis industry, and the Company, together with its directors and executives, is executing on a business plan focused on supplying the international marketplace.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this press release.

Forward-Looking Statements

This press release contains forward-looking statements. Forward-looking statements can be identified by the use of words such as, "expects", "is expected", "intends", "believes", or variations of such words and phrases or state that certain actions, events or results "may" or "will" be taken, occur or be achieved. Forward-looking statements include statements with respect to the vesting of RSUs. Such forward-looking statements are based on assumptions, including compliance with the RSU Plan enabling the RSUs to vest. Forward-looking statements can be affected by known and unknown risks, uncertainties and other factors, including, but not limited to, the equity markets generally, risks associated with early stage companies, risks associated with the regulation of cannabis and cannabinoid derivatives, failure to obtain necessary TSXV approval, competition for PharmaCielo's planned products, risks associated with operating in Colombia, and currency exchange risk. Accordingly, readers should not place undue reliance on forward-looking statements.

Except as required by law, PharmaCielo undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this press release.

SOURCE PharmaCielo Ltd.

USA vs. China

Diese Unternehmen hat kaum ein Anleger auf dem Zettel: die Profiteure des Handels­konflikts zwischen China und den USA. Welche das sind, erfahren Sie heute im Webinar ...

Jetzt kostenlos anmelden!
Werbung
Werbung
Börse Stuttgart Anlegerclub

Die richtige Strategie für die Börsenkrise

Stecken Sie nicht den Sand in den Kopf, sondern kaufen Sie die richtigen Aktien. Erfahren Sie im aktuellen Anlegermagazin mehr über attraktive Qualitätsaktien und zyklische Aktien
Kostenfrei registrieren und lesen!

Heute im Fokus

DAX mit neuem Hoch -- Aroundtown legt Offerte für TLG vor -- thyssenkrupp beauftragt wohl Bank mit Untersuchung von Industrial Solutions -- Drägerwerk, easyJet, VW, MorphoSys im Fokus

Home Depot senkt Prognose für Umsatzwachstum im Gesamtjahr. Deutsche Börse offenbar ebenfalls mit möglichem Interesse an BME. innogy liefert Solarstrom an Audax in Spanien. Boeing ergattert 737-MAX-Aufträge im Wert von 5,9 Mrd Dollar. easyJet bestellt bei Airbus zwölf A320neo. BofA mit Kaufempfehlung: Aurubis-Aktie springt auf Hoch seit April.

Die 5 beliebtesten Top-Rankings

Hohe Ausgaben
Die beliebtesten Weihnachtsgeschenke 2019
Das Schwarzbuch 2019
Wo 2019 sinnlos Steuern verbrannt wurden
Die wertvollsten Marken der Welt 2019
Diese Unternehmen sind vorne mit dabei
Die beliebtesten Arbeitgeber in Deutschland
Hier arbeiten die Deutschen am liebsten
Die Performance der TecDAX-Werte im Oktober 2019.
Welche Aktie macht das Rennen?
mehr Top Rankings

Umfrage

Wo sehen Sie den Bitcoin-Kurs Ende 2019?

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
Wirecard AG747206
Ballard Power Inc.A0RENB
NEL ASAA0B733
Daimler AG710000
Deutsche Bank AG514000
Volkswagen (VW) AG Vz.766403
Microsoft Corp.870747
EVOTEC SE566480
Apple Inc.865985
Aurora Cannabis IncA12GS7
K+S AGKSAG88
AramcoARCO11
Amazon906866
CommerzbankCBK100
BASFBASF11